Human amniotic mesenchymal stem cell-conditioned medium inhibited LPS-induced cell injury and inflammation by modulating CD14/TLR4-mediated signaling …
M Li, T Li, J Jin, C Xie, J Zhu - Molecular Immunology, 2023 - Elsevier
Human amniotic mesenchymal stem cells (hAMSCs) have attracted considerable attention
as a promising regenerative therapy. Many studies reported that the conditioned medium of …
as a promising regenerative therapy. Many studies reported that the conditioned medium of …
Human amniotic mesenchymal stem cell-conditioned medium inhibited LPS-induced cell injury and inflammation by modulating CD14/TLR4-mediated signaling …
M Li, T Li, J Jin, C Xie, J Zhu - Molecular immunology, 2023 - pubmed.ncbi.nlm.nih.gov
Human amniotic mesenchymal stem cells (hAMSCs) have attracted considerable attention
as a promising regenerative therapy. Many studies reported that the conditioned medium of …
as a promising regenerative therapy. Many studies reported that the conditioned medium of …
Human amniotic mesenchymal stem cell-conditioned medium inhibited LPS-induced cell injury and inflammation by modulating CD14/TLR4-mediated signaling …
M Li, T Li, J Jin, C Xie, J Zhu - Molecular Immunology, 2023 - europepmc.org
Human amniotic mesenchymal stem cells (hAMSCs) have attracted considerable attention
as a promising regenerative therapy. Many studies reported that the conditioned medium of …
as a promising regenerative therapy. Many studies reported that the conditioned medium of …